Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Cost of revenue11¢$162.6K
- Research and development18¢$273.4K
- Interest71¢$1.1M
Out of $285.3K in revenue.23 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $96.2K5 | $1.2K6 | $57.1K7 | $234.4K3 | $285.3K2 | ||
| Cost of revenue | $41.8K5 | $7156 | $37.1K7 | $197.2K7 | $162.6K3 | ||
| Gross profit | $54.4K5 | $4736 | $20.0K7 | $54.2K3 | $122.7K2 | ||
| Research and development | $78.9K8 | $08 | $108.9K6 | $10.1K10 | $13.9K7 | $6.9K3 | $273.4K3 |
| Operating income | -$4.0M8 | -$2.0M9 | -$1.5M6 | -$1.9M10 | -$1.1M7 | -$2.0M3 | -$3.4M3 |
| Interest | $4.8K11 | $280.6K7 | $902.2K3 | $1.1M3 | |||
| Net income | -$5.1M8 | -$2.6M9 | -$2.2M6 | -$36.1K10 | -$1.1M7 | -$3.0M3 | -$3.6M3 |
| Earnings per share | $0.009 | $0.009 | |||||
| Earnings per share (diluted) | -$0.006 | -$0.0110 | -$0.027 | -$0.047 |
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $209.1K9 | $1810 | $12.3K10 | $385.9K7 | $5.3K3 | $49.8K3 | |
| Current assets | $333.4K8 | $3.2K9 | $2.8K6 | $686.3K10 | $947.8K7 | $607.9K3 | $2.4M3 |
| Total assets | $358.6K8 | $10.2K9 | $3.8K6 | $688.8K10 | $960.8K7 | $643.5K3 | $2.5M3 |
| Current liabilities | $1.7M8 | $2.3M9 | $2.0M6 | $318.6K10 | $457.4K7 | $942.7K3 | $1.2M3 |
| Total liabilities | $2.1M6 | $393.6K10 | $457.4K7 | $951.7K3 | $1.2M3 | ||
| Shareholders’ equity | -$1.3M9 | -$2.3M9 | -$2.1M6 | $295.3K7 | $503.4K3 | -$308.2K3 | $1.3M3 |
| Shares outstanding | 899.0M shares8 | 1.4B shares8 | 2.1B shares9 | 4.1B shares6 | 72.9M shares10 | 145.3M shares7 | 287.9M shares3 |
What it owns
What TAURIGA SCIENCES, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Accumulated depreciation | $1.6K3 Mar 31, 2021 | $56.2K3 Mar 31, 2020 | −97.1% |
| Property and equipment, net | $12.1K3 Mar 31, 2021 | $13.5K3 Mar 31, 2020 | −10.5% |
| Operating-lease assets (leased space) | $64.3K3 Mar 31, 2021 | $22.1K3 Mar 31, 2020 | +191.1% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $49.8K3 Mar 31, 2021 | $5.3K3 Mar 31, 2020 | +831.7% |
Inventory
Leadership
Who has led TAURIGA SCIENCES, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerStella M. Sung Jun 25, 2014 to Mar 30, 201512
- Chief executive officerSeth M. Shaw Oct 5, 2012 to May 27, 202113
- Chief financial officerKevin Patrick Lacey Jul 13, 2017 to Jul 13, 201714
- Chief financial officerGhalia Lahlou Apr 22, 2016 to Apr 22, 201615
- Chief financial officerBruce Harmon Oct 18, 2012 to Dec 31, 201216
- Chief operating officerStella M. Sung May 15, 2013 to Dec 13, 201317
Board members and other officers (7)
- Board memberChris Sferruzzo Apr 14, 2021 to Apr 14, 202118
- Board memberJames Rosati V. Apr 20, 2021 to Apr 20, 202119
- Board memberDavid L. Wolitzky Apr 22, 2016 to Apr 22, 201620
- Board memberKeith Berman Apr 29, 2016 to Apr 29, 201621
- Board memberHingge Hsu Jan 27, 2015 to Apr 22, 201622
- Board memberStella M. Sung May 15, 2013 to Mar 30, 201517
- Board memberSeth M. Shaw Oct 5, 2012 to May 27, 202113
Former names
Timeline
Filings
9 filings to the SEC since October 2021: 2 quarterly reports, 1 major events, 6 other. The latest 9:
- May 8, 2024REVOKED EDGAR
- Aug 16, 2022NT 10-Q EDGAR
- Jul 14, 2022NT 10-K/A EDGAR
- Jun 30, 2022NT 10-K EDGAR
- Feb 16, 202210-Q EDGAR
- Feb 15, 2022NT 10-Q EDGAR
- Nov 23, 20218-K EDGAR
- Nov 15, 202110-Q EDGAR
- Oct 12, 2021DEF 14A EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How TAURIGA SCIENCES, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARTAURIGA SCIENCES, INC.1
- CIK0001142790
- Employer ID (EIN)65-11022371
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inFlorida1
- Fiscal year endsMarch 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address4 Nancy Court, Suite 4, Wappingers Falls, NY 125901
- Phone917-796-99261
- Shares outstanding299,908,214 as of Feb 15, 20222
- Public float$5.7M as of Sep 30, 20203
- On EDGAR sinceJun 20, 20011
- Filings411 in all: 8-K (127), 4 (47), 10-Q (42), NT 10-Q (31), 10QSB (20), NT 10-K (14), 10-K (13), 3 (13)1
All 38 form types
UPLOAD (9), 10-Q/A (7), 10KSB (7), POS AM (6), PRE 14A (6), 10QSB/A (5), 8-K/A (5), CORRESP (5), DEF 14A (5), 10-K/A (4), S-8 (4), SC 13D/A (4), 4/A (3), 424B3 (3), D (3), EFFECT (3), PRER14A (3), SB-2/A (3), SC 13G (3), DEFA14A (2), S-1 (2), S-8 POS (2), SC 13D (2), SC 13G/A (2), 8-A12G (1), NT 10-K/A (1), PREM14C (1), REVOKED (1), S-1/A (1), SB-2 (1)
- Latest filingsAnnual report (10-K) Jun 29, 2021
Quarterly report (10-Q) Feb 16, 2022
Proxy statement (DEF 14A) Oct 12, 2021
Latest 8-K (8-K) Nov 23, 2021
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARChris Sferruzzo, Board member
- 19SEC EDGARJames Rosati V., Board member
- 20SEC EDGARDavid L. Wolitzky, Board member
- 21SEC EDGARKeith Berman, Board member
- 22SEC EDGARHingge Hsu, Board member
- 23